Katov, L.; Rostan, J.; Teumer, Y.; Diofano, F.; Bothner, C.; Rottbauer, W.; Weinmann-Emhardt, K.
Antiarrhythmic Effects of SGLT2 Inhibitors on Supraventricular Tachyarrhythmias in Patients with HFrEF. J. Clin. Med. 2025, 14, 786.
https://doi.org/10.3390/jcm14030786
AMA Style
Katov L, Rostan J, Teumer Y, Diofano F, Bothner C, Rottbauer W, Weinmann-Emhardt K.
Antiarrhythmic Effects of SGLT2 Inhibitors on Supraventricular Tachyarrhythmias in Patients with HFrEF. Journal of Clinical Medicine. 2025; 14(3):786.
https://doi.org/10.3390/jcm14030786
Chicago/Turabian Style
Katov, Lyuboslav, Jonas Rostan, Yannick Teumer, Federica Diofano, Carlo Bothner, Wolfgang Rottbauer, and Karolina Weinmann-Emhardt.
2025. "Antiarrhythmic Effects of SGLT2 Inhibitors on Supraventricular Tachyarrhythmias in Patients with HFrEF" Journal of Clinical Medicine 14, no. 3: 786.
https://doi.org/10.3390/jcm14030786
APA Style
Katov, L., Rostan, J., Teumer, Y., Diofano, F., Bothner, C., Rottbauer, W., & Weinmann-Emhardt, K.
(2025). Antiarrhythmic Effects of SGLT2 Inhibitors on Supraventricular Tachyarrhythmias in Patients with HFrEF. Journal of Clinical Medicine, 14(3), 786.
https://doi.org/10.3390/jcm14030786
